Cargando…
Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis
The safety of other biologic therapies in rheumatoid arthritis (RA) following B cell-depletion therapy with rituximab has not been established. This retrospective chart review of patients attending an outpatient rheumatology clinic aimed to assess the incidence of adverse events in patients receivin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824288/ https://www.ncbi.nlm.nih.gov/pubmed/20091035 http://dx.doi.org/10.1007/s00296-009-1307-7 |